Literature DB >> 15115780

Characterization of cell lines stably expressing human normal or mutated EGFP-tagged MC4R.

Antonine Blondet1, Mabrouka Doghman, Mohamed Rached, Philippe Durand, Martine Bégeot, Danielle Naville.   

Abstract

The melanocortin receptor type 4 (MC4-R) is involved in food intake and represents a potential target for the treatment of some forms of obesity. The fluorescent protein EGFP was fused to the wild-type or mutated coding sequence of the human MC4-R. After transfection in HEK 293, clones stably expressing hMC4-R-EGFP were selected. Wild-type chimeric hMC4-R was well addressed to the cell membrane as demonstrated using confocal microscopy and displayed the same pharmacological characteristics as native hMC4R. NDP-alpha MSH induced a time-dependent internalization of MC4-R that was partially prevented by AgRP. The two mutated chimeric receptors studied here (CTCT-deleted and C271A) showed a high alteration of their response to ligand and were retained inside the cells. In conclusion, we have developed a model of clones stably expressing EGFP-tagged-hMC4-R. This is the only such model available to date and it provides a useful tool to follow the trafficking of MC4-R inside living cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15115780     DOI: 10.1093/jb/mvh064

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  5 in total

1.  Hormonal regulation of the mouse adrenal melanocortinergic system.

Authors:  Y Soltani; M Doghman; J Gout; V Rebuffet; M Vigier; F Hadj Bekkouche; D Naville; M Begeot
Journal:  J Endocrinol Invest       Date:  2009-01       Impact factor: 4.256

2.  Differential Signaling Profiles of MC4R Mutations with Three Different Ligands.

Authors:  Sarah Paisdzior; Ioanna Maria Dimitriou; Paul Curtis Schöpe; Paolo Annibale; Patrick Scheerer; Heiko Krude; Martin J Lohse; Heike Biebermann; Peter Kühnen
Journal:  Int J Mol Sci       Date:  2020-02-12       Impact factor: 5.923

3.  MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family.

Authors:  Li F Chan; Tom R Webb; Teng-Teng Chung; Eirini Meimaridou; Sadani N Cooray; Leonardo Guasti; J Paul Chapple; Michaela Egertová; Maurice R Elphick; Michael E Cheetham; Louise A Metherell; Adrian J L Clark
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-27       Impact factor: 11.205

4.  The majority of adrenocorticotropin receptor (melanocortin 2 receptor) mutations found in familial glucocorticoid deficiency type 1 lead to defective trafficking of the receptor to the cell surface.

Authors:  T T Chung; T R Webb; L F Chan; S N Cooray; L A Metherell; P J King; J P Chapple; A J L Clark
Journal:  J Clin Endocrinol Metab       Date:  2008-10-07       Impact factor: 5.958

5.  Curbing Inflammation through Endogenous Pathways: Focus on Melanocortin Peptides.

Authors:  Tazeen J Ahmed; Trinidad Montero-Melendez; Mauro Perretti; Costantino Pitzalis
Journal:  Int J Inflam       Date:  2013-05-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.